Progress Pulmonary Fibrosis
Conditions
Interventions
Observation group:NA
Sponsors
Peking Union Medical College Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Diagnosis of PPF within the past year, according to the 2022 ATS/ERS/JRS/ALAT guidelines; 2. Patients who are willing to participate in the study and have signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients diagnosed with IPF. 2.Patients without baseline chest HRCT. 3. Patients who refuse to sign the informed consent form. 4. Patients participating in other clinical trials for medications. (Patients who have completed other trials or are in an unblinded phase after a washout period of 2 weeks are eligible for enrollment.);
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Forced Vital Capacity, FVC; | — |
Secondary
| Measure | Time frame |
|---|---|
| Connective Tissue Disease Associated Interstitial Lung Disease, CTD-ILD;Hypersensitivity Pneumonitis, HP;Idiopathic Non-Specific Interstitial Pneumonitis, iNSIP; | — |
Countries
China
Contacts
Public ContactXu Zuojun
Peking Union Medical College Hospital
Outcome results
None listed